Results 221 to 230 of about 125,690 (294)
Current and emerging medical and surgical therapy in hypertrophic cardiomyopathy. [PDF]
J Cardiovasc ImagingKim KA, Jung MH.
europepmc +1 more source
Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations [PDF]
, 2001 Paal Skytt Andersen
openalex +1 more source
The Journal of Physiology, EarlyView.Abstract figure legend Using a multiscale computational model of left ventricular electromechanics, we investigated how sarcomere dynamics influence the end‐systolic pressure‐volume (ESPV) relationship in ejecting beats compared to isovolumetric beats.
Francesco Regazzoni +2 more
wiley +1 more source
The Journal of Physiology, EarlyView.Abstract figure legend A sudden decrease in total peripheral resistance (TPR), as observed during vasovagal syncope, leads to a reduction in aortic systolic pressure (AO pressure) and afterload. In healthy individuals, the consequent decrease in left ventricular systolic pressure (LV pressure) lowers stroke work and myocardial energy expenditure.
Martin Dvoulety, Michal Sitina
wiley +1 more source
Relationships between QRS duration and left ventricular deformation in hypertrophic cardiomyopathy. [PDF]
Quant Imaging Med SurgChen S +7 more
europepmc +1 more source
14‐3‐3 proteins: Regulators of cardiac excitation–contraction coupling and stress responses
The Journal of Physiology, EarlyView.Abstract figure legend 14‐3‐3 protein interactions in cardiac regulation. Schematic representation of 14‐3‐3 binding partners in excitation–contraction coupling, transcriptional regulation/development and stress response pathways. Asterisks indicate targets where the exact 14‐3‐3 binding site is unknown.
Heather C. Spooner, Rose E. Dixon
wiley +1 more source
Addressing discrepancies in symptom and psychosocial assessments in hypertrophic cardiomyopathy. [PDF]
Int J Cardiol Cardiovasc Risk PrevSathian B +3 more
europepmc +1 more source